The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials
- PMID: 31821323
- PMCID: PMC6903706
- DOI: 10.1371/journal.pmed.1002884
The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials
Abstract
Andrew Vernon and co-authors discuss adherence to therapy and its measurement in tuberculosis treatment trials.
Conflict of interest statement
All the authors work on TB clinical trials; PN, RS, and AV collaborate as part of the TB Trials Consortium, supported by CDC.
References
-
- Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946–1986, with relevant subsequent publications. Int J Tuberc Lung Dis. 1999. October;3(10 Suppl 2):S231–79. - PubMed
-
- Kent PW, Fox W, Miller AB, Nunn AJ, Tall R, Mitchison DA. The therapy of pulmonary tuberculosis in Kenya: a comparison of the results achieved in controlled clinical trials with those achieved by the routine treatment services. Tubercle. 1970. March; 51(1):24–38. 10.1016/0041-3879(70)90125-x - DOI - PubMed
